Where is Day Zero Diagnostics headquartered?

Day Zero Diagnostics is located in Boston, MA.

Who invested in Day Zero Diagnostics?

Day Zero Diagnostics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Day Zero Diagnostics raised to date?

Day Zero Diagnostics has raised ____.

When was the last funding round for Day Zero Diagnostics?

Day Zero Diagnostics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

dayzerodiagnostics.com

Day Zero Diagnostics

Day Zero Diagnostics is a Massachusetts-based biotechnology company that offers solutions such as infectious disease diagnosis and genomic sequencing for bloodstream infections.

Business Model:

Revenue: $1.5M

Employees: 11-50

Geographic Data

Address: 40 Guest Street

City: Boston

State: MA

Zip: 02135

Country: US

Financial Info

Stage:

series unknown

Raised Last:

$21M

Raised Total:

$39M

Social

Facebook

Twitter

Crunchbase

Metrics

9,495,887Website Global Rank

147Website Monthly Traffic

Twitter Followers

Description

Day Zero Diagnostics is a Massachusetts-based biotechnology company that offers solutions such as infectious disease diagnosis and genomic sequencing for bloodstream infections.

Contact Phone:
+16179492684

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2020	Grant	1	-	National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases
10/2022	Grant		$8.2M	CARB-X
5/2017	Equity		$2.5M
7/2019	Grant	1	-	National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases
9/2017	Grant	1	-	MedTech Innovator MedTech Innovator
5/2020	Grant	1	$6.2M	CARB-X CARB-X
8/2017	Seed Round	2	$3M	Golden Seeds Sands Capital Ventures Golden Seeds Sands Capital Ventures
2/2022	Venture Round		$0	Becton Dickinson India Golden Seeds Hongkou Capital Panacea Venture Sands Capital Ventures Triventures Becton Dickinson India Golden Seeds Hongkou Capital Panacea Venture Sands Capital Ventures Triventures
1/2019	Series A	1	$8.6M	Triventures Triventures Triventures Triventures
5/2017	Non Equity Assistance	1	-	MassChallenge MassChallenge
1/2019	Series A	1	$8.6M	Triventures Triventures
10/2022	Grant	1	$8.2M	CARB-X CARB-X CARB-X CARB-X CARB-X CARB-X
2/2022	Venture Round	6	$21M	Sands Capital Becton, Dickinson and Company Panacea Venture Hongkou Capital Triventures Golden Seeds Becton Dickinson India Golden Seeds Hongkou Capital Panacea Venture Sands Capital Ventures Triventures
12/2020	Grant	1	-	National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases
7/2019	Grant	1	-	National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases
9/2017	Grant	1	-	MedTech Innovator MedTech Innovator
5/2017	Non Equity Assistance	1	-

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details